Compare AdaptHealth Corp (AHCO) vs iShares MSCI China ETF (MCHI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs iShares MSCI China ETF — how do they compare? AdaptHealth Corp trades at $10.04 (market cap $1.38B), while iShares MSCI China ETF trades at $52.88. The key difference: AdaptHealth Corp is trading nearer its 52-week high, iShares MSCI China ETF nearer its low. Which is the better fit depends on your goals.
| AHCO | MCHI | |
|---|---|---|
Market Cap | $1.38B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $13.38 | $66.99 |
52-Week Low | $8.68 | $50.48 |
Enterprise Value | $3.33B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
MCHI trades at $52.02, up 2.18% today, amid a bearish technical signal with moving averages indicating selling pressure and oscillators neutral. The stock faces resistance at $52. Recent news highlights China's AI and export-driven factory rebound, which could benefit broad China ETFs like MCHI, but structural headwinds and value trap risks persist according to some analysts.
The outlook remains cautious due to mixed technicals and macroeconomic uncertainties. Opportunities exist if China's tech and manufacturing recovery accelerates, but risks include U.S.-China tensions, deflationary pressures, and potential regulatory changes. Investors should weigh the ETF's exposure to China's cyclical sectors against its attractive valuation multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About iShares MSCI China ETF
MCHI is an ETF that seeks to track the investment results of the MSCI China Index. It provides broad exposure to the Chinese equity market, primarily focusing on large and mid-cap companies listed in Hong Kong and Shanghai. MCHI serves as a core holding for investors looking to gain diversified exposure to the performance and growth potential of the companies within the People's Republic of China.
Read more on MCHI →
